Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma
Open Access
Abstract
Background: The influence of obesity and sex on outcomes in pancreatic adenocarcinoma (PDAC) remains unclear. The association between obesity (body mass index [BMI], ≥30) and biologic sex (male or female) for outcomes in patients with PDAC undergoing a surgery‐first approach was investigated. Methods: A prospectively maintained pancreatic cancer database at the Memorial Sloan Kettering Cancer Center was queried to identify all patients undergoing surgery with a pathologic diagnosis of PDAC. Clinicodemographic variables, outcomes, and tumor mutational analyses for all available patients were collected. Cumulative incidence of first recurrence involving the liver was estimated via a cumulative incidence function. Multivariable Cox regression was used to investigate the association between BMI and sex for overall survival. Results: From 2012 to 2022, 939 patients were identified who underwent surgery with a final pathologic diagnosis of PDAC. Median age was 70 years, 52% were male, and 24% were obese (BMI, ≥30). When dichotomized by sex and obesity status (BMI, <30 or ≥30), females with obesity had the lowest cumulative incidence of liver recurrence at 12 and 24 months postsurgery compared to all other groups (13% [95% CI, 7.2%–20%] and 15% [8.7%–23%], respectively). Females with obesity had the longest median overall survival at 37 months. Conclusions: After curative surgery for pancreatic cancer, females with obesity have a significantly lower rate of liver recurrence and the longest median overall survival. This does not appear to be related to surgical quality, receipt of adjuvant therapy, or tumor mutational profile. Investigation into host immune, metabolic, and hormonal parameters is paramount to understanding these differences.Keywords
Funding Information
- National Cancer Institute (P30 CA008748)
This publication has 26 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liverInternational Journal of Oncology, 2011
- Influence of Sex Hormones on Cancer ProgressionJournal of Clinical Oncology, 2010
- Impact of Obesity on Perioperative Outcomes and Survival Following Pancreaticoduodenectomy for Pancreatic Cancer: A Large Single-Institution StudyJournal of Gastrointestinal Surgery, 2010
- Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohortsCancer Causes & Control, 2010
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic CancerJAMA, 2009
- The effects of cancer chemotherapy on liver imagingEuropean Radiology, 2009
- Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancersCancer Detection Prevention, 2008
- Fatty Liver: Imaging Patterns and PitfallsRadioGraphics, 2006